FI951249A - Serotiinireseptoriaineita - Google Patents
Serotiinireseptoriaineita Download PDFInfo
- Publication number
- FI951249A FI951249A FI951249A FI951249A FI951249A FI 951249 A FI951249 A FI 951249A FI 951249 A FI951249 A FI 951249A FI 951249 A FI951249 A FI 951249A FI 951249 A FI951249 A FI 951249A
- Authority
- FI
- Finland
- Prior art keywords
- represented
- hydrogen
- alkyl
- optionally substituted
- chx1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Jellies, Jams, And Syrups (AREA)
- Dental Preparations (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94700792A | 1992-09-17 | 1992-09-17 | |
| US7969293A | 1993-06-17 | 1993-06-17 | |
| US08/119,791 US5436246A (en) | 1992-09-17 | 1993-09-15 | Serotonin receptor agents |
| PCT/US1993/008865 WO1994006789A1 (en) | 1992-09-17 | 1993-09-17 | Serotonin receptor agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI951249A true FI951249A (fi) | 1995-03-16 |
| FI951249A0 FI951249A0 (fi) | 1995-03-16 |
Family
ID=27373532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI951249A FI951249A0 (fi) | 1992-09-17 | 1995-03-16 | Serotiinireseptoriaineita |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5436246A (fi) |
| EP (1) | EP0660832B1 (fi) |
| JP (1) | JP3298107B2 (fi) |
| KR (1) | KR100195809B1 (fi) |
| AT (1) | ATE162190T1 (fi) |
| AU (1) | AU671494B2 (fi) |
| CA (1) | CA2144947C (fi) |
| DE (1) | DE69316377T2 (fi) |
| ES (1) | ES2112434T3 (fi) |
| FI (1) | FI951249A0 (fi) |
| GR (1) | GR3026297T3 (fi) |
| HU (1) | HU222725B1 (fi) |
| NO (1) | NO310461B1 (fi) |
| NZ (1) | NZ256561A (fi) |
| WO (1) | WO1994006789A1 (fi) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
| WO1996003400A1 (en) * | 1994-07-26 | 1996-02-08 | Pfizer Inc. | 4-indole derivatives as serotonin agonists and antagonists |
| FR2735127B1 (fr) * | 1995-06-09 | 1997-08-22 | Pf Medicament | Nouvelles piperazines heteroaromatiques utiles comme medicaments. |
| GB9517381D0 (en) * | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
| NZ331860A (en) | 1996-03-29 | 2000-04-28 | Duphar Int Res | Piperazine and piperidine compounds with affinity for both dopamine D2 and seratonin 5-HT1A receptors |
| TR199801929T2 (xx) | 1996-03-29 | 1998-12-21 | Pfizer Inc. | Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� . |
| FR2761068B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique |
| FR2763243A1 (fr) * | 1997-05-14 | 1998-11-20 | Pf Medicament | Utilisation d'amines indoliques comme medicaments antithrombotiques |
| EP0900792B1 (en) * | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists |
| TW530054B (en) | 1997-09-24 | 2003-05-01 | Duphar Int Res | New piperazine and piperidine compounds |
| EP1204660B1 (en) * | 1999-07-29 | 2004-10-20 | Eli Lilly And Company | Serotonergic benzothiophenes |
| GB0005789D0 (en) | 2000-03-11 | 2000-05-03 | Knoll Ag | Therapeutic agents |
| US6969730B2 (en) * | 2001-03-16 | 2005-11-29 | Abbott Laboratories | Amines as histamine-3 receptor ligands and their therapeutic applications |
| EP1370546A2 (en) * | 2001-03-16 | 2003-12-17 | Abbott Laboratories | Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| US20050080084A1 (en) * | 2003-07-11 | 2005-04-14 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage |
| CA2536340A1 (en) * | 2003-08-22 | 2005-03-03 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia |
| US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
| US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
| WO2006101454A1 (en) * | 2005-03-21 | 2006-09-28 | S*Bio Pte Ltd | Benzothiophene derivatives: preparation and pharmaceutical applications |
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JP4315393B2 (ja) * | 2005-04-14 | 2009-08-19 | 大塚製薬株式会社 | 複素環化合物 |
| US20060252825A1 (en) * | 2005-04-22 | 2006-11-09 | Wyeth | Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
| CN103380129B (zh) * | 2010-12-20 | 2016-04-20 | 阿克图拉姆生命科学股份公司 | 2-甲酰胺-4-哌嗪基-苯并呋喃衍生物 |
| EP2736894B1 (en) * | 2011-07-28 | 2016-08-31 | Otsuka Pharmaceutical Co., Ltd. | Method for producing benzo[b] thiophene compounds |
| CN104557896A (zh) | 2013-10-18 | 2015-04-29 | 沈敬山 | 布瑞哌唑、其关键中间体及其盐的制备方法 |
| CN105732572A (zh) * | 2014-12-10 | 2016-07-06 | 苏州鹏旭医药科技有限公司 | 一种Brexpiprazole中间体的制备方法及Brexpiprazole中间体 |
| EP3150591A1 (en) | 2015-10-02 | 2017-04-05 | Crystal Pharma S.A.U | Process and intermediates for the preparation of benzo[b]thiophene compounds |
| CN107663384B (zh) * | 2016-07-20 | 2020-05-12 | 上海高驰资产管理有限公司 | 一种荧光染料及其制备方法和用途 |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK169601B1 (da) * | 1983-10-17 | 1994-12-19 | Duphar Int Res | Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse |
| GB8406906D0 (en) * | 1984-03-16 | 1984-04-18 | Akzo Nv | Benzo-thiazole and benzothiophene derivatives |
| ATE81975T1 (de) * | 1984-12-21 | 1992-11-15 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
| DE3571436D1 (en) * | 1984-12-21 | 1989-08-17 | Duphar Int Res | New pharmaceutical compositions having anti-psychotic properties |
| DE58902111D1 (de) * | 1988-03-16 | 1992-10-01 | Ciba Geigy Ag | Thioverbindungen. |
| NL8802997A (nl) * | 1988-12-07 | 1990-07-02 | Philips Nv | Weergeefinrichting. |
| US5032598A (en) * | 1989-12-08 | 1991-07-16 | Merck & Co., Inc. | Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents |
| FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
-
1993
- 1993-09-15 US US08/119,791 patent/US5436246A/en not_active Expired - Lifetime
- 1993-09-17 DE DE69316377T patent/DE69316377T2/de not_active Expired - Fee Related
- 1993-09-17 NZ NZ256561A patent/NZ256561A/en unknown
- 1993-09-17 ES ES93922253T patent/ES2112434T3/es not_active Expired - Lifetime
- 1993-09-17 CA CA002144947A patent/CA2144947C/en not_active Expired - Fee Related
- 1993-09-17 KR KR1019950701026A patent/KR100195809B1/ko not_active IP Right Cessation
- 1993-09-17 AT AT93922253T patent/ATE162190T1/de not_active IP Right Cessation
- 1993-09-17 JP JP50837194A patent/JP3298107B2/ja not_active Expired - Fee Related
- 1993-09-17 HU HU9500796A patent/HU222725B1/hu not_active IP Right Cessation
- 1993-09-17 AU AU51321/93A patent/AU671494B2/en not_active Ceased
- 1993-09-17 EP EP93922253A patent/EP0660832B1/en not_active Expired - Lifetime
- 1993-09-17 WO PCT/US1993/008865 patent/WO1994006789A1/en active IP Right Grant
-
1995
- 1995-03-16 NO NO19951015A patent/NO310461B1/no not_active IP Right Cessation
- 1995-03-16 FI FI951249A patent/FI951249A0/fi unknown
-
1998
- 1998-03-06 GR GR980400468T patent/GR3026297T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI951249A0 (fi) | 1995-03-16 |
| NO310461B1 (no) | 2001-07-09 |
| AU5132193A (en) | 1994-04-12 |
| JP3298107B2 (ja) | 2002-07-02 |
| AU671494B2 (en) | 1996-08-29 |
| JPH08501559A (ja) | 1996-02-20 |
| NO951015L (no) | 1995-05-15 |
| EP0660832B1 (en) | 1998-01-14 |
| EP0660832A1 (en) | 1995-07-05 |
| CA2144947A1 (en) | 1994-03-31 |
| CA2144947C (en) | 2000-02-01 |
| ATE162190T1 (de) | 1998-01-15 |
| HUT72662A (en) | 1996-05-28 |
| NZ256561A (en) | 1996-06-25 |
| US5436246A (en) | 1995-07-25 |
| ES2112434T3 (es) | 1998-04-01 |
| GR3026297T3 (en) | 1998-06-30 |
| KR950703558A (ko) | 1995-09-20 |
| DE69316377D1 (de) | 1998-02-19 |
| DE69316377T2 (de) | 1998-08-27 |
| NO951015D0 (no) | 1995-03-16 |
| KR100195809B1 (ko) | 1999-06-15 |
| WO1994006789A1 (en) | 1994-03-31 |
| HU9500796D0 (en) | 1995-05-29 |
| HU222725B1 (hu) | 2003-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI951249A (fi) | Serotiinireseptoriaineita | |
| AU2001272476A1 (en) | Piperidines for use as orexin receptor antagonists | |
| US4136095A (en) | 5,9α-Imino- or 6,9α-iminomethylene-9-deoxy-PGF1 compounds | |
| ES8506633A1 (es) | Un procedimiento para la preparacion de dihidropiridinas. | |
| BG102959A (en) | Benzooxazinon antagonists of domamine d4 receptor | |
| FI834730A0 (fi) | 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat | |
| ES8609304A1 (es) | Procedimiento para la obtencion de derivados de indol | |
| EP0089765A3 (en) | Pyridine derivatives | |
| TW222268B (fi) | ||
| EP0379085A3 (de) | Phenylalkylamine und diese enthaltende Fungizide | |
| EP0076089A3 (en) | Azabicycloalkane derivatives, process for their preparation, and a pharmaceutical composition containing them | |
| IE812913L (en) | Sulphonyl azabicyclo benzamides | |
| ES8502699A1 (es) | Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas | |
| ES8105981A1 (es) | Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina | |
| ES8506605A1 (es) | Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas | |
| SE8301785L (sv) | Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning | |
| FI865057A0 (fi) | Nya fluorhaltiga 1,4-dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| ES8801542A1 (es) | Procedimiento para preparar compuestos arilsulfonicos. | |
| ES8307233A1 (es) | Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico. | |
| ES477709A1 (es) | Procedimiento de preparacion de nuevos compuestos cis- y trans-1,5-benzotiacepinicos. | |
| FI941650A0 (fi) | Uudet fluorikinolin-3-karboksyylihappojohdannaiset ja niiden valmistus | |
| ES8407030A1 (es) | Un procedimiento para prepararacion de derivados del triazol. | |
| ES8500904A1 (es) | Procedimiento para preparar indolaminas sustituidas. | |
| ES482462A1 (es) | Procedimiento para la preparacion de 2-fenilbiciclooctanos. | |
| ES474282A1 (es) | Un procedimiento para producir un compuesto de piridazinoma. |